FindTrial
Sign In

Canceled by the investigator. Comparative study on follicular fluid metabolomics in infertility with polycystic ovary syndrome or endometriosis

Comparative study on follicular fluid metabolomics in infertility with polycystic ovary syndrome or endometriosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078410
Enrollment
Unknown
Registered
2023-12-07
Start date
2023-12-10
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Infertility polycystic ovary syndrome group, infertility endometriosis group:None

Sponsors

School of Medical and Life Sciences/Reproductive & Women-Children Hospital,Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: ? Female patients aged 20-45 years old; ?Patients accepting assisted reproductive technology in vitro fertilization and embryo transfer technology; ? Infertility patients who meet the criteria of polycystic ovary syndrome or endometriosis or are solely male factors; ? Volunteers to participate in the study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: ? Patients with congenital gonadal hypoplasia, diabetes, thyroid dysfunction; ? Individuals with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney, lung, and hematopoietic systems, as well as psychiatric patients; ? One or both of the couple with chromosomal abnormalities.

Design outcomes

Primary

MeasureTime frame
metabolomics;—

Countries

China

Contacts

Public ContactLv Zili

School of Medical and Life Sciences/Reproductive & Women-Children Hospital,Chengdu University of Traditional Chinese Medicine

233597789@qq.com+86 180 0807 8069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026